Senior insider sale
Chief Financial Officer at VIKING THERAPEUTICS, INC. — senior position signals high conviction
$216.5K
6.18K shares
What this filing means
ZANTE GREG plans to sell 6.18K shares of VIKING THERAPEUTICS, INC. valued at approximately $216.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/28/2025ACC: 0001950047-25-008235
Officer· Chief Financial Officer
Since Jan 2021
6.18K
Shares to sell
$216.5K
Approx. market value
6.18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Performance Stock Units
Not Applicable
10/27/2025
6.18KTotal acquired6.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/27/2025 | Performance Stock Units Not Applicable | 6.18K | — |
| Total | 6.18K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.18K
Market value
$216.5K
10/28/2025
Total
Units
6.18K
Value
$216.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/28/2025 | 6.18K | $216.5K | NASDAQ | Planned |
| Total | 6.18K | $216.5K | ||